These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 11127760

  • 1. The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms.
    Speroff L, Symons J, Kempfert N, Rowan J, femhrt Study Investigators.
    Menopause; 2000; 7(6):383-90. PubMed ID: 11127760
    [Abstract] [Full Text] [Related]

  • 2. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
    Rowan JP, Simon JA, Speroff L, Ellman H.
    Clin Ther; 2006 Jun; 28(6):921-32. PubMed ID: 16860174
    [Abstract] [Full Text] [Related]

  • 3. Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators.
    Symons J, Kempfert N, Speroff L.
    Obstet Gynecol; 2000 Sep; 96(3):366-72. PubMed ID: 10960627
    [Abstract] [Full Text] [Related]

  • 4. Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens.
    Simon JA, Symons JP, femhrt Study Investigators.
    Menopause; 2001 Sep; 8(5):321-7. PubMed ID: 11528357
    [Abstract] [Full Text] [Related]

  • 5. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ, Symons J, Menon S, HT Study Group.
    J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
    [Abstract] [Full Text] [Related]

  • 6. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA, Liu JH, Speroff L, Shumel BS, Symons JP.
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M, Cassel D, Hille D, Furst KW, Dain MP, VandePol C, Skarinsky D.
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [Abstract] [Full Text] [Related]

  • 8. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
    Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS.
    Menopause; 2006 Jan; 13(5):780-6. PubMed ID: 16894334
    [Abstract] [Full Text] [Related]

  • 9. A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms.
    Botteman MF, Shah NP, Lian J, Pashos CL, Simon JA.
    Menopause; 2004 Jan; 11(3):343-55. PubMed ID: 15167315
    [Abstract] [Full Text] [Related]

  • 10. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
    Speroff L, Rowan J, Symons J, Genant H, Wilborn W.
    JAMA; 1996 Nov 06; 276(17):1397-403. PubMed ID: 8892714
    [Abstract] [Full Text] [Related]

  • 11. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
    Baerug U, Winge T, Nordland G, Faber-Swensson E, Heldaas K, Norling B, Larsen S, Arce JC.
    Climacteric; 1998 Sep 06; 1(3):219-28. PubMed ID: 11907946
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
    Weisberg E, Fraser IS, Mishell DR, Lacarra M, Darney P, Jackanicz TM.
    Contraception; 1999 May 06; 59(5):305-10. PubMed ID: 10494484
    [Abstract] [Full Text] [Related]

  • 13. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS, Rose PA, Kim HM, Kehrer C, Brook RD.
    J Womens Health (Larchmt); 2007 Sep 06; 16(7):963-70. PubMed ID: 17903073
    [Abstract] [Full Text] [Related]

  • 14. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
    Adler G, Young D, Galant R, Quinn L, Witchger MS, Maki KC.
    Gynecol Obstet Invest; 2005 Sep 06; 59(4):212-9. PubMed ID: 15753617
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
    Portman DJ, Symons JP, Wilborn W, Kempfert NJ.
    Am J Obstet Gynecol; 2003 Feb 06; 188(2):334-42. PubMed ID: 12592236
    [Abstract] [Full Text] [Related]

  • 16. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
    Bruhat M, Rudolf K, Vaheri R, Kainulainen P, Timonen U, Viitanen A.
    Maturitas; 2001 Dec 14; 40(3):259-71. PubMed ID: 11731187
    [Abstract] [Full Text] [Related]

  • 17. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E, Fraser IS, Lacarra M, Mishell DR, Alvarez F, Brache V, Nash HA.
    Contraception; 1999 May 14; 59(5):311-8. PubMed ID: 10494485
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.
    Rozenbaum H, Chevallier O, Moyal M, Durand G, Perineau M, This P, Aerodiol study group.
    Climacteric; 2002 Sep 14; 5(3):249-58. PubMed ID: 12419083
    [Abstract] [Full Text] [Related]

  • 19. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Suparto IH, Williams JK, Cline JM, Anthony MS, Fox JL.
    Am J Obstet Gynecol; 2003 May 14; 188(5):1132-40. PubMed ID: 12748457
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Merz CN, Olson MB, McClure C, Yang YC, Symons J, Sopko G, Kelsey SF, Handberg E, Johnson BD, Cooper-DeHoff RM, Sharaf B, Rogers WJ, Pepine CJ.
    Am Heart J; 2010 Jun 14; 159(6):987.e1-7. PubMed ID: 20569710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.